Utility of comet assay of DNA damage in the detection of malignant transformation of chronic liver cirrhosis

References

• Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249.
   PubMed Web of Science ®Google Scholar
• Trinchet JC, Bourcier V, Chaffaut C, et al. Complications and competing risks of death in compensated viral cirrhosis (ANRS CO12 CirVir prospective cohort). Hepatology. 2015;62(3):737–750.
   PubMed Web of Science ®Google Scholar
• European Association for the Study of the Liver. EASL clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2018;69:182–236.
   PubMed Web of Science ®Google Scholar
• Zhou WC, Zhang QB, Qiao L. Pathogenesis of liver cirrhosis. World J Gastroenterol. 2014;20(23):7312–7324.
   PubMed Web of Science ®Google Scholar
• Llovet JM, Kelley RK, Villanueva A, et al. Hepatocellular carcinoma. Nat Rev Dis Primers. 2021;7(1):6.
   PubMed Web of Science ®Google Scholar
• Li S, Tan HY, Wang N, et al. The role of oxidative stress and antioxidants in liver diseases. Int J Mol Sci. 2015;16(11):26087–26124.
   PubMed Web of Science ®Google Scholar
• Rybicka M, Woziwodzka A, Sznarkowska A, et al. Liver cirrhosis in chronic hepatitis B patients is associated with genetic variations in DNA repair pathway genes. Cancers. 2020;12(11):3295.
   PubMed Web of Science ®Google Scholar
• Elzehery R, Effat N, El Farahaty R, et al. Circulating cell-free DNA and DNA integrity as molecular diagnostic tools in hepatocellular carcinoma. Am J Clin Pathol. 2022;158(2):254–262.
   PubMed Web of Science ®Google Scholar
• Shawki SM, Meshaal SS, El Dash AS, et al. Increased DNA damage in hepatitis C virus-related hepatocellular carcinoma. DNA Cell Biol. 2014;33(12):884–890.
   PubMed Web of Science ®Google Scholar
• Lou J, He J, Zheng W, et al. Investigating the genetic instability in the peripheral lymphocytes of 36 untreated lung cancer patients with comet assay and micronucleus assay. Mutat Res. 2007;617(1–2):104–110.
   PubMed Web of Science ®Google Scholar
• Kuchařová M, Hronek M, Rybáková K, et al. Comet assay and its use for evaluating oxidative DNA damage in some pathological states. Physiol Res. 2019;68(1):1–15.
   PubMed Web of Science ®Google Scholar
• Lu Y, Liu Y, Yang C. Evaluating in vitro DNA damage using comet assay. J Vis Exp. 2017;128:56450.
   Google Scholar
• Shah AJ, Lakkad BC, Rao MV. Genotoxicity in lead treated human lymphocytes evaluated by micronucleus and comet assays. Indian J Exp Biol. 2016;54(8):502–508.
   PubMed Web of Science ®Google Scholar
• Sykora P, Witt KL, Revanna P, et al. Next generation high throughput DNA damage detection platform for genotoxic compound screening. Sci Rep. 2018;8(1):2771.
   PubMedGoogle Scholar
• Nandhakumar S, Parasuraman S, Shanmugam MM, et al. Evaluation of DNA damage using single-cell gel electrophoresis (comet assay). J Pharmacol Pharmacother. 2011;2(2):107–111.
   PubMedGoogle Scholar
• Kiziltan E, Yurtcu E. Semi-automatic scoring tool for comet assay. J Serb Soc Comp Mech. 2015;9(2):27–33.
   Google Scholar
• Furlan A, Marin D, Vanzulli A, et al. Hepatocellular carcinoma in cirrhotic patients at multidetector CT: hepatic venous phase versus delayed phase for the detection of tumour washout. Br J Radiol. 2011;84(1001):403–412.
   PubMed Web of Science ®Google Scholar
• Sherman M. Limitations of screening for hepatocellular carcinoma. Hepat Oncol. 2014;1(2):161–163.
   PubMedGoogle Scholar
• Johnstone EC, Lind MJ, Griffin MJ, et al. Ifosfamide metabolism and DNA damage in tumour and peripheral blood lymphocytes of breast cancer patients. Cancer Chemother Pharmacol. 2000;46(6):433–441.
   PubMed Web of Science ®Google Scholar
• McKenna DJ, McKeown SR, McKelvey-Martin VJ. Potential use of the comet assay in the clinical management of cancer. Mutagenesis. 2008;23(3):183–190.
   PubMed Web of Science ®Google Scholar
• Apostolou P, Toloudi M, Kourtidou E, et al. Use of the comet assay technique for quick and reliable prediction of in vitro response to chemotherapeutics in breast and colon cancer. J Biol Res. 2014;21(1):14.
   Google Scholar
• Sanche P, Penarroja R, Gallegos F, et al. DNA damage in peripheral lymphocytes of untreated breast cancer patients. Arch Med Res. 2004;35(6):480–483.
   PubMed Web of Science ®Google Scholar
• Vodicka P, Vodenkova S, Opattova A, et al. DNA damage and repair measured by comet assay in cancer patients. Mutat Res Genet Toxicol Environ Mutagen. 2019;843:95–110.
   PubMed Web of Science ®Google Scholar
• Mammel AE, Hatch EM. Genome instability from nuclear catastrophe and DNA damage. Semin Cell Dev Biol. 2022;123:131–139.
   PubMed Web of Science ®Google Scholar
• Grossi S, Sumberaz A, Gosmar M, et al. DNA damage in peripheral blood lymphocytes of patients with cirrhosis related to alcohol abuse or to hepatitis B and C viruses. Eur J Gastroenterol Hepatol. 2008;20(1):22–25.
   PubMed Web of Science ®Google Scholar
• Farinati F, Cardin R, Degan P, et al. Oxidative DNA damage in circulating leukocytes occurs as an early event in chronic HCV infection. Free Radic Biol Med. 1999;27(11–12):1284–1291.
   PubMed Web of Science ®Google Scholar
• Cardin R, Saccoccio G, Masutti F, et al. DNA oxidative damage in leukocytes correlates with the severity of HCV-related liver disease: validation in an open population study. J Hepatol. 2001;34(4):587–592.
   PubMed Web of Science ®Google Scholar
• Bolukbas C, Bolukbas FF, Kocyigit A, et al. Relationship between levels of DNA damage in lymphocytes and histopathological severity of chronic hepatitis C and various forms of hepatitis B. J Gastroenterol Hepatol. 2006;21(3):610–616.
   PubMed Web of Science ®Google Scholar
• Reshetnyak VI, Sharafanova TI, Ilchenko LU, et al. Peripheral blood lymphocytes DNA in patients with chronic liver diseases. World J Gastroenterol. 2001;7(2):235–237.
   PubMed Web of Science ®Google Scholar
• Wang SC, Lai KR, Li CY, et al. The paradoxical effects of different hepatitis C viral loads on host DNA damage and repair abilities. PLOS One. 2017;12(1):e0164281.
   PubMed Web of Science ®Google Scholar
• Committee on Mutagenicity of Chemicals in Food, Consumer Products and the Environment. Statement 2018/S1: statement on the quantitative approaches to the assessment of genotoxicity; Centre for Radiation, Chemical and Environmental Hazards Chilton, Didcot, Oxfordshire, 2018.
   Google Scholar